Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
CN Sternberg, ID Davis, J Mardiak, C Szczylik, E Lee, J Wagstaff, CH Barrios, P Salman, OA Gladkov, A Kavina, JJ Zarbá, M Chen, L McCann, L Pandite, DF Roychowdhury, RE Hawkins
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
J Clin Oncol. 2010 Jan 25;[Epub Ahead of Print], CN Sternberg, ID Davis, J Mardiak, C Szczylik, E Lee, J Wagstaff, CH Barrios, P Salman, OA Gladkov, A Kavina, JJ Zarbá, M Chen, L McCann, L Pandite, DF Roychowdhury, RE Hawkins
ABSTRACT
In this randomized, double-blind, multinational, phase III study, pazopanib significantly improved both PFS and response rates when compared with placebo.